NFE2L2 and acute myeloid leukemia: Therefore, targeting the Nrf2-ALDH2/PolG2 pathway can both alter mitochondrial respiration and inhibit mtDNA synthesis to disrupt mitochondrial homoeostasis and increase the sensitivity of AML cells to chemotherapy drugs.